These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2867036)
1. Ocular changes associated with long term phenothiazine usage. Alexander TA; John JK; Thomas A; Verghese A Indian J Ophthalmol; 1985; 33(1):27-31. PubMed ID: 2867036 [No Abstract] [Full Text] [Related]
2. [Ocular complications in long-term chlorpromazine treatment]. Klíma M; Klímová A Cesk Oftalmol; 1977 Sep; 33(5):349-52. PubMed ID: 922908 [No Abstract] [Full Text] [Related]
3. [Ocular pigmentation and phenothiazine derivatives]. Calluaud JL; Di Battista JC; Douenne JL; Lagoutte F Bull Soc Ophtalmol Fr; 1977; 77(7-8):661-4. PubMed ID: 26474 [No Abstract] [Full Text] [Related]
5. Incidence of late "melanosis" side effects in chronic mental patients after long term phenothiazine therapy. Forrest FM; Snow HL; Erickson G; Geiter CW; Laxson GO Proc West Pharmacol Soc; 1966; 9():18-20. PubMed ID: 5958492 [No Abstract] [Full Text] [Related]
6. [Prevention and correction of the side effects of psychopharmacologic agents on the eye]. Gol'dovskaia IL Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):90-4. PubMed ID: 1971137 [TBL] [Abstract][Full Text] [Related]
7. Ocular changes and phenothiazine derivatives in long-term residents of a mental retardation center. Gowdey CW; Coleman LM; Crawford EM Psychiatr J Univ Ott; 1985 Dec; 10(4):248-53. PubMed ID: 2868472 [No Abstract] [Full Text] [Related]
8. Asymmetric anterior segment changes induced by chlorpromazine. Deluise VP; Flynn JT Ann Ophthalmol; 1981 Aug; 13(8):953-5. PubMed ID: 7294636 [TBL] [Abstract][Full Text] [Related]
10. Ocular and cutaneous effects of chronic phenothiazine therapy. Bond WS; Yee GC Am J Hosp Pharm; 1980 Jan; 37(1):74-8. PubMed ID: 6102438 [No Abstract] [Full Text] [Related]
11. [Ocular involvement during prolonged treatment with neuroleptics]. Nouri A; Cuendet JF Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196 [No Abstract] [Full Text] [Related]
12. What is appropriate disclosure? Cohen D Can Fam Physician; 1999 Sep; 45():2036, 2038. PubMed ID: 10509210 [No Abstract] [Full Text] [Related]
13. Adverse reactions to chlorpromazine in psychiatric patients. Swett C Dis Nerv Syst; 1974 Nov; 35(11):509-11. PubMed ID: 17896459 [TBL] [Abstract][Full Text] [Related]
14. Allergic and photoallergic conditions from unusual chlorpromazine exposure: report of three cases. Giomi B; Difonzo EM; Lotti L; Massi D; Francalanci S Int J Dermatol; 2011 Oct; 50(10):1276-8. PubMed ID: 21950296 [No Abstract] [Full Text] [Related]
15. [Ocular changes in long-term treatment with Largactil]. Kalberer M; Atar Z; Bider E Ophthalmologica; 1970; 161(2):118-24. PubMed ID: 4989755 [No Abstract] [Full Text] [Related]
16. Withdrawal symptoms after long-term treatment with low-potency neuroleptics. Chouinard G; Bradwejn J; Annable L; Jones BD; Ross-Chouinard A J Clin Psychiatry; 1984 Dec; 45(12):500-2. PubMed ID: 6150030 [TBL] [Abstract][Full Text] [Related]
17. A Case Report: Anti-Psychotic Agents Related Ocular Toxicity. Choy BNK; Ng ALK; Shum JWH; Fan MCY; Lai JSM Medicine (Baltimore); 2016 Apr; 95(15):e3360. PubMed ID: 27082594 [TBL] [Abstract][Full Text] [Related]
19. Ocular effects of phenothiazine derivatives and reversibility. Mathalone MB Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561 [No Abstract] [Full Text] [Related]
20. Cutaneous and ocular changes associated with the use of chlorpromazine. Wolf ME; Richer S; Berk MA; Mosnaim AD Int J Clin Pharmacol Ther Toxicol; 1993 Aug; 31(8):365-7. PubMed ID: 8225679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]